Photodermatology, Photoimmunology & Photomedicine
© John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
Edited By: Thomas M. Rünger
Impact Factor: 1.516
ISI Journal Citation Reports © Ranking: 2012: 28/59 (Dermatology)
Online ISSN: 1600-0781
Online submission of manuscripts
Authors are required to submit manuscripts online via ScholarOne Manuscript (http://mc.manuscriptcentral.com/photo). Manuscripts must be submitted as Word (doc) files, charts as Excel (xls) files and figures submitted as high resolution JPEG files. Do not embed figures within the main text; apend them as separate files. Authors must provide a 100-word summary along with the manuscript, which may be used by the Editor to highlight the manuscript when it is published.
Authors for whom English is a second language may choose to have their manuscript professionally edited before submission. We are unable to accept any Manuscript submitted in inaccessible English or in a form unsuitable for effective peer review (http://authorservices.wiley.com/bauthor/english_language.asp).
Authors submitting a paper do so on the understanding that the work has not been published before, is not being considered for publication elsewhere and has been read and approved by all authors. Photodermatology, Photoimmunology & Photomedicine employs a plagiarism detection system. By submitting your manuscript to this journal you accept that your manuscript may be screened for plagiarism against previously published works.
Prior to submission, authors should carefully check the Ethical guidelines document available here.
If you need further instructions for electronic submission of manuscripts please contact:
Thomas M. Rünger
Chair of the Department of Dermatology
Roger Williams Medical Center
Providence, RI 02908
Professor of Dermatology, Pathology and Laboratory Medicine
Boston University School of Medicine
9600 Garsington Road
Tel: +1 410 847 3700
Fax: +1 410 847 3703
Copyright Transfer Agreement
If your paper is accepted, the author identified as the formal corresponding author for the paper will receive an email prompting them to login into Author Services; where via the Wiley Author Licensing Service (WALS) they will be able to complete the license agreement on behalf of all authors on the paper.
For authors signing the copyright transfer agreement
If the OnlineOpen option is not selected the corresponding author will be presented with the copyright transfer agreement (CTA) to sign. The terms and conditions of the CTA can be previewed in the samples associated with the Copyright FAQs.
For authors choosing OnlineOpen
If the OnlineOpen option is selected the corresponding author will have a choice of the following Creative Commons License Open Access Agreements (OAA):
Creative Commons Attribution License OAA
Creative Commons Attribution Non-Commercial License OAA
Creative Commons Attribution Non-Commercial -NoDerivs License OAA
To preview the terms and conditions of these open access agreements please visit the Copyright FAQs hosted on Wiley Author Services and visit http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html.
If you select the OnlineOpen option and your research is funded by The Wellcome Trust and members of the Research Councils UK (RCUK) you will be given the opportunity to publish your article under a CC-BY license supporting you in complying with Wellcome Trust and Research Councils UK requirements. For more information on this policy and the Journal’s compliant self-archiving policy please visit: http://www.wiley.com/go/funderstatement.
Style of writing
Use a succinct style of writing. State the objectives of the study clearly, but avoid lengthy introductions. Refrain from overwriting the Results section, e.g., by making extensive cross-tabulations or otherwise presenting too many details of subordinate interest; rather, concentrate on a few important findings. In the Discussion, do not repeat in detail data given in the Results section, but instead emphasize the new and important aspects of the study. State clearly the implications and conclusions of the study. Remember that the editorial processing of concisely written manuscripts will be much more rapid than that of lengthy, complicated articles that have to be sent back to the author for remodeling.
Photodermatology, Photoimmunology & Photomedicine accepts original articles, review articles, letters to the editor and invited commentaries. Authors must pay for color illustrations at a rate to be quoted by the publisher (not applicable for review articles).
Original articles are investigations of experimental and pathological processes in humans or animals in vivo or investigations of radiation effects in cells or tissues in vitro. It should not exceed 3500 words, including an abstract of 250 words and legends (excluding references), and a maximum of 6 figures or tables.
Review articles, including new trends, are ordinarily solicited by the Editors, although we invite suggestions from all readers. There is no word limit but authors are encouraged to be concise and should provide an abstract of 250 words.
Letters to the Editor are intended for the brief reporting of a special observation, either clinical or experimental, or of interesting patient cases. They can also respond to previously published articles in Photodermatology, Photoimmunology & Photomedicine, to address a hypothesis, or to make a single point. They should not exceed 1500 words, including legends (excluding references), and have a maximum of 2 figures or tables and 10 references. No abstract is required.
Invited commentaries address a hypothesis or a single point, as they relate to a published article in the same issue of Photodermatology, Photoimmunology & Photomedicine. They should be 1000 - 2000 words in length, including an abstract of 100 words and legends (excluding references), and have a maximum of 2 figures or tables and 10 references. Subheadings are encouraged. If appropriate, three bullet points concerning clinical relevance may be included.
The paper should be submitted in English. Type the manuscript double spaced, with margins of at least 25 mm (1 inch). Each manuscript component should begin on a new page in the following sequence: title page; abstract and key words (3 to 5); text; acknowledgements; references; tables; each table, complete with title and footnotes, on a separate page; legends for illustration. Number pages consecutively, beginning with the title page. Type the page number in the upper right-hand corner of each page. Number the tables consecutively with Arabic numerals. For any further details, consult the 'Uniform requirements for manuscripts submitted to biomedical journals', Ref. 2 below.
This must be structured into the following blocks: Background/purpose, Methods, Results, Conclusion.
All figures should clarify the text and their number should be kept to a minimum. Details must be large enough to retain their clarity after reduction.
It is the policy of Photodermatology, Photoimmunology & Photomedicine for authors to pay the full cost for the reproduction of their colour artwork (not applicable for Invited Review Articles). Therefore, please note that if there is colour artwork in your manuscript when it is accepted for publication, Wiley-Blackwell requires you to complete and return a Colour Work Agreement Form before your manuscript can be published. The first colour figure is £150 and subsequent figures are £50 each. Any article received by Wiley-Blackwell with colour work will not be published until the form has been returned.
Abbreviations and symbols
Use only standard abbreviations. All units will be metric. Use no Roman numerals in the text. In decimals, a decimal point, and not a comma, will be used. Consult the CBE style manual: a guide for authors, editors and publishers in the biological sciences, 4th edn., Arlington, Virginia, 1978. Avoid abbreviations in the title. The full term for which an abbreviation stands should precede its first use in the text unless it is a standard unit of measurement. Units of measurement should be expressed in accordance with the SI and CIE recommendations (see Ref. 3, below). For photodermatologic terminology, consult recent issues of Photodermatology, Photoimmunology & Photomedicine.
Number references consecutively in the order in which they are first mentioned in the text. Identify references in text, tables and legends by Arabic numerals (in parentheses). List all authors cited, and only these, at the end of the paper. Journal titles should be abbreviated according to the style used in Index Medicus.
1. Standard journal article
(List all authors when 6 or less; when 7 or more, list only the first 3 and add et al.)
Parrish J A, Fitzpatrick T B, Tanebaum L, Pathak M A. Photochemotherapy with oral methoxsalen and long wave ultraviolet light. N Engl J Med 1974: 291: 1207-1222.
2. Corporate author
International Committee of Medical Journal Editors. Uniform requirements for manuscripts submitted to biomedical journals. Br Med J 1988: 296: 401-405.
3. Agency publication
International lightning vocabulary. Paris: Bureau Central de la Commission International de l'Eclairage, 1970; Vol. 3.
Armstrong Lowe D. A guide to international recommendations on names and symbols for quantities and on units of measurement. Geneva: WHO, 1975 (Progress in Standardization, No. 2).
4. Chapter in a book
Frain-Bell W. The photodermatoses. In: Rook A, ed. Recent advances in dermatology. Edinburgh: Churchill Livingstone, 1973: 101-133.
Conflict of Interest
Authors have a responsibility to disclose interests that might appear to affect their ability to present data objectively. These include relevant financial (for example, patent ownership, stock ownership, consultancies, speaker’s fees), personal, political, intellectual, or religious interests. Although the Editors will not reject a paper simply because of a competing interest, they will publish a statement of declared interests.
All original articles require a summary statement of about 100 words. This should summarize what is known about the subject and/or the reason for doing the study, the results and their implications or applications. The summary statement is distinct and different to the abstract and should be written in easily understood prose.
Manuscripts may be revised within the editorial office. Only in case of extensive corrections will the manuscript be returned to the authors for final approval. The corresponding author will receive an email alert containing a link to a web site. A working email address must therefore be provided for the corresponding author. Further instructions will be sent with the proof.
Online production tracking is now available for your article through Wiley-Blackwell’s Author Services. Author Services enables authors to track their article - once it has been accepted - through the production process to publication online and in print. Authors can check the status of their articles online and choose to receive automated e-mails at key stages of production so they don’t need to contact the production editor to check on progress. Visit authorservices.wiley.com/bauthor/ for more details on online production tracking and for a wealth of resources including FAQs and tips on article preparation, submission and more.
Photodermatology, Photoimmunology and Photomedicine now offers Accepted Articles for all manuscripts. This service ensures that accepted 'in press' manuscripts are published online very soon after acceptance, prior to copy-editing or typesetting. Accepted Articles appear in PDF-only format, without the accompanying full-text HTML. Each manuscript is assigned a Digital Object Identifier (DOI), which allows the article to be cited and tracked before it is allocated to an issue. After print publication, the DOI remains valid and can continue to be used to cite and access the article.
Photodermatology, Photoimmunology and Photomedicine is now available via the Early View service. Early View articles are complete full-text articles published online in advance of their publication in a printed issue. Articles are therefore available as soon as they are ready, rather than having to wait for the next scheduled print issue. Early View articles are complete and final. They have been fully reviewed, revised and edited for publication, and the authors’ final corrections have been incorporated. Because they are in final form, no changes can be made after online publication. They are given a Digital Object Identifier (DOI), which allows the article to be cited and tracked. After publication, the DOI remains valid and can continue to be used to cite and access the article.
The corresponding author will receive an electronic PDF offprint of his or her article via Author Services. Additional offprints can be ordered via http://offprint.cosprinters.com/.
OnlineOpen is available to authors of primary research articles who wish to make their article available to non-subscribers on publication, or whose funding agency requires grantees to archive the final version of their article. With OnlineOpen, the author, the author's funding agency, or the author's institution pays a fee to ensure that the article is made available to non-subscribers upon publication via Wiley Online Library, as well as deposited in the funding agency's preferred archive. For the full list of terms and conditions, see http://wileyonlinelibrary.com/onlineopen#OnlineOpen_Terms
Any authors wishing to send their paper OnlineOpen will be required to complete the payment form available from our website at:
Prior to acceptance there is no requirement to inform an Editorial Office that you intend to publish your paper OnlineOpen if you do not wish to. All OnlineOpen articles are treated in the same way as any other article. They go through the journal's standard peer-review process and will be accepted or rejected based on their own merit.
Author material archive policy
Please note that unless specifically requested, Wiley-Blackwell will dispose of all hardcopy or electronic material submitted four months/ two issues after publication. If you require the return of any material submitted, please inform the editorial office or production editor as soon as possible if you have not yet done so.